Title : Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.

Pub. Date : 2014 Sep

PMID : 24953979






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Novel, non-quinazoline, EGFR inhibitors, that also target EGFR activating and resistance (T790M) mutations, are currently under clinical development. Quinazolines epidermal growth factor receptor Homo sapiens